News for Fairmount Partners

August 2017: News

Fairmount is the most active M&A firm based in the Mid-Atlantic, with a national and international practice.  Since 2003, the firm has completed more than 185 transactions throughout North and South America, Europe, Asia and Australia.   Fairmount specializes in advising middle-market companies on sell-side, buy-side and capital placement transactions, and provides fairness opinions and strategic advice in the transaction context.

  • Represented ThreeWire®, the global leader in clinical trial recruitment and direct-to-patient marketing, in its acquisition by WIRB-Copernicus Group® (WCG™), the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research.   ThreeWire® uses a systematic, patient-focused approach to help biopharmaceutical and medical device companies and clinical research organizations achieve their clinical trial enrollment and retention goals.  Having screened over 2 million patients in more than 25 countries, ThreeWire’s disciplined, proven approach consistently produces measurable, predictable results for its U.S. and overseas clients.
  • Represented Altasciences Company, Inc., a leading early phase contract research organization (CRO), in its acquisition by Audax Private Equity in partnership with Altasciences management. Audax acquired Altasciences from Kilmer Capital Partners, a private equity firm based in Toronto, Canada.  Altasciences, headquartered in Laval, Quebec, encompasses Algorithme Pharma, Vince & Associates Clinical Research, and Algorithme Pharma USA.  Altasciences offers expertise in the execution of a wide range of New Drug Application (NDA) enabling clinical trials and support services including data management, biostatistics, medical writing, and bioanalysis.

 


©2017 PACT All Rights Reserved